Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis

Journal of the American Society of Nephrology

Volumn 21, Issue 9, 2010, Pages 1445-1455

  Hamano, Yuki ^a   Okude, Takashi ^b   Shirai, Ryota ^b   Sato, Ikumi ^b   Kimura, Ryota ^b   Ogawa, Makoto ^a,c   Ueda, Yoshihiko ^d   Yokosuka, Osamu ^c   Kalluri, Raghu ^e   Ueda, Shiro ^b  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 18; ENDOSTATIN; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BOWMAN CAPSULE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; KIDNEY TUBULE BASEMENT MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; AMINO ACID SEQUENCE; ANIMAL; BASEMENT MEMBRANE; C57BL MOUSE; DEFICIENCY; FEMALE; MALE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BASEMENT MEMBRANE; BOWMAN CAPSULE; COLLAGEN TYPE XVIII; COMPLEMENT C3; ENDOSTATINS; FEMALE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956551545     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009050492     Document Type: Article

References (45)

1. Kalluri R: Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003
2. Timpl R: Structure and biological activity of basement membrane proteins. Eur J Biochem 180: 487-502, 1989 (Pubitemid 19111111)
3. Raats CJ, Van Den Born J, Berden JH: Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney Int 57: 385-400, 2000 (Pubitemid 30430630)
4. Iozzo RV: Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 67: 609-652, 1998
5. Rops AL, Gotte M, Baselmans MH, van den Hoven MJ, Steenbergen EJ, Lensen JF, Wijnhoven TJ, Cevikbas F, van den Heuvel LP, van Kuppevelt TH, Berden JH, van der Vlag J: Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int 72: 1204-1215, 2007
6. Jackson RL, Busch SJ, Cardin AD: Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71: 481-539, 1991
7. Marneros AG, Olsen BR: Physiological role of collagen XVIII and endostatin. FASEB J 19: 716-728, 2005 (Pubitemid 40617376)
8. Utriainen A, Sormunen R, Kettunen M, Carvalhaes LS, Sajanti E, Eklund L, Kauppinen R, Kitten GT, Pihlajaniemi T: Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum Mol Genet 13: 2089-2099, 2004
9. Miosge N, Simniok T, Sprysch P, Herken R: The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J Histochem Cytochem 51: 285-296, 2003 (Pubitemid 36245984)
10. Marneros AG, Keene DR, Hansen U, Fukai N, Moulton K, Goletz PL, Moiseyev G, Pawlyk BS, Halfter W, Dong S, Shibata M, Li T, Crouch RK, Bruckner P, Olsen BR: Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J 23: 89-99, 2004
11. Passos-Bueno MR, Suzuki OT, Armelin-Correa LM, Sertie AL, Errera FI, Bagatini K, Kok F, Leite KR: Mutations in collagen 181 and their relevance to the human phenotype. An Acad Bras Cienc 78: 123-131, 2006
12. Boehm T, Folkman J, Browder T, O'Reilly MS: Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404-407, 1997 (Pubitemid 28027321)
13. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997
14. Standker L, Schrader M, Kanse SM, Jurgens M, Forssmann WG, Preissner KT: Isolation and characterization of the circulating form of human endostatin. FEBS Lett 420: 129-133, 1997 (Pubitemid 28037226)
15. Marneros AG, Olsen BR: The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol 20: 337-345, 2001
16. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, Sukhatme VP: Endostatin induces endothelial cell apoptosis. J Biol Chem 274: 11721-11726, 1999 (Pubitemid 129518427)
17. Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkila P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T: Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307: 292-304, 2005 (Pubitemid 40799357)
18. Sund M, Hamano Y, Sugimoto H, Sudhakar A, Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A, Kalluri R: Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci U S A 102: 2934-2939, 2005 (Pubitemid 40299894)
19. Seppinen L, Sormunen R, Soini Y, Elamaa H, Heljasvaara R, Pihlajaniemi T: Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol 27: 535-546, 2008
20. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ: The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 4: 575-580, 1998 (Pubitemid 28237356)
21. Park SY, Ueda S, Ohno H, Hamano Y, Tanaka M, Shiratori T, Yamazaki T, Arase H, Arase N, Karasawa A, Sato S, Ledermann B, Kondo Y, Okumura K, Ra C, Saito T: Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Invest 102: 1229-1238, 1998 (Pubitemid 28436283)
22. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol 151: 1231-1239, 1997 (Pubitemid 27479752)
23. Daniel C, Amann K, Hohenstein B, Bornstein P, Hugo C: Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice. J Am Soc Nephrol 18: 788-798, 2007 (Pubitemid 46434496)
24. Shimizu A, Masuda Y, Mori T, Kitamura H, Ishizaki M, Sugisaki Y, Fukuda Y: Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat antiglomerular basement membrane glomerulonephritis. J Am Soc Nephrol 15: 2655-2665, 2004 (Pubitemid 41103372)
25. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R: Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins. Proc Natl Acad Sci U S A 100: 4766-4771, 2003 (Pubitemid 36457804)
26. Hanai J, Gloy J, Karumanchi SA, Kale S, Tang J, Hu G, Chan B, Ramchandran R, Jha V, Sukhatme VP, Sokol S: Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol 158: 529-539, 2002 (Pubitemid 34851711)
27. Moulton KS, Olsen BR, Sonn S, Fukai N, Zurakowski D, Zeng X: Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 110: 1330-1336, 2004 (Pubitemid 39202354)
28. Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, Niemela M, Ilves M, Li E, Pihlajaniemi T, Olsen BR: Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J 21: 1535-1544, 2002 (Pubitemid 34614610)
29. Li Q, Olsen BR: Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am J Pathol 165: 415-424, 2004 (Pubitemid 38971372)
30. Fujii T, Hamano Y, Ueda S, Akikusa B, Yamasaki S, Ogawa M, Saisho H, Verbeek JS, Taki S, Saito T: Predominant role of FcγRIII in the induction of accelerated nephrotoxic glomerulonephritis. Kidney Int 64: 1406-1416, 2003 (Pubitemid 37153807)
31. Isome M, Fujinaka H, Adhikary LP, Kovalenko P, El-Shemi AG, Yoshida Y, Yaoita E, Takeishi T, Takeya M, Naito M, Suzuki H, Yamamoto T: Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats. Nephrol Dial Transplant 19: 2997-3004, 2004 (Pubitemid 40057620)
32. Schrijver G, Bogman MJ, Assmann KJ, de Waal RM, Robben HC, van Gasteren H, Koene RA: Anti-GBM nephritis in the mouse: Role of granulocytes in the heterologous phase. Kidney Int 38: 86-95, 1990 (Pubitemid 20209436)
33. Feith GW, Assmann KJ, Bogman MJ, van Gompel AP, Schalkwijk J, Koene RA: Lack of albuminuria in the early heterologous phase of anti-GBM nephritis in beige mice. Kidney Int 43: 824-827, 1993 (Pubitemid 23105215)
34. Javaherian K, Park SY, Pickl WF, LaMontagne KR, Sjin RT, Gillies S, Lo KM: Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J Biol Chem 277: 45211-45218, 2002 (Pubitemid 36159125)
35. Sertie AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR: Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet 9: 2051-2058, 2000 (Pubitemid 30642670)
36. Hansen PM, Chowdhury T, Deckert T, Hellgren A, Bain SC, Pociot F: Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients. Diabetes 46: 1658-1659, 1997 (Pubitemid 27411246)
37. Celie JW, Rutjes NW, Keuning ED, Soininen R, Heljasvaara R, Pihlajaniemi T, Drager AM, Zweegman S, Kessler FL, Beelen RH, Florquin S, Aten J, van den Born J: Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein- 1 ligands upon renal ischemia/reperfusion. Am J Pathol 170: 1865-1878, 2007
38. Kawashima H, Watanabe N, Hirose M, Sun X, Atarashi K, Kimura T, Shikata K, Matsuda M, Ogawa D, Heljasvaara R, Rehn M, Pihlajaniemi T, Miyasaka M: Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J Biol Chem 278: 13069-13076, 2003 (Pubitemid 36800075)
39. Rops AL, van der Vlag J, Lensen JF, Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, Berden JH: Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int 65: 768-785, 2004 (Pubitemid 38251053)
40. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147: 1715-1727, 1995
41. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13: 806-816, 2002 (Pubitemid 34183950)
42. Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K: A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. Cancer Res 65: 3656-3663, 2005 (Pubitemid 40616342)
43. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R: Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608, 2003 (Pubitemid 36800018)
44. Hamano Y, Grunkemeyer JA, Sudhakar A, Zeisberg M, Cosgrove D, Morello R, Lee B, Sugimoto H, Kalluri R: Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 277: 31154-31162, 2002 (Pubitemid 34970821)
45. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R: Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275: 21340-21348, 2000 (Pubitemid 30481833)